E

Enzymatica AB (publ)
STO:ENZY

Watchlist Manager
Enzymatica AB (publ)
STO:ENZY
Watchlist
Price: 1.8 SEK 3.45% Market Closed
Market Cap: 436.9m SEK
Have any thoughts about
Enzymatica AB (publ)?
Write Note

Wall Street
Price Targets

ENZY Price Targets Summary
Enzymatica AB (publ)

Wall Street analysts forecast ENZY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENZY is 3.96 SEK with a low forecast of 2.71 SEK and a high forecast of 5.34 SEK.

Lowest
Price Target
2.71 SEK
50% Upside
Average
Price Target
3.96 SEK
120% Upside
Highest
Price Target
5.34 SEK
197% Upside
Enzymatica AB (publ) Competitors:
Price Targets
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
57% Upside
4503
Astellas Pharma Inc
27% Upside
KLBF
Kalbe Farma Tbk PT
21% Upside
ALKEM
Alkem Laboratories Ltd
4% Upside
4577
Daito Pharmaceutical Co Ltd
32% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
32% Upside
BSEM
Biostem Technologies Inc
138% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Enzymatica AB (publ)

For the last 8 years the compound annual growth rate for Enzymatica AB (publ)'s revenue is 8%. The projected CAGR for the next 3 years is 30%.

8%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Enzymatica AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Enzymatica AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENZY's stock price target?
Price Target
3.96 SEK

According to Wall Street analysts, the average 1-year price target for ENZY is 3.96 SEK with a low forecast of 2.71 SEK and a high forecast of 5.34 SEK.

What is Enzymatica AB (publ)'s Revenue forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Enzymatica AB (publ)'s revenue is 8%. The projected CAGR for the next 3 years is 30%.

Back to Top